Literature DB >> 16068184

Structural polymorphism of human DR antigens.

J Silver, S Ferrone.   

Abstract

DR ANTIGENS are polymorphic cell surface molecules whose expression is controlled by a locus closely linked or identical to the D locus of the major histocompatibility complex (MHC) of man (for reviews see refs 1, 2). They are functionally and structurally homologous to the murine la antigens determined by the I-E subregion of the MHC, a region which has been implicated in the genetic control of immune responses(3,4). Both sets of antigens are mainly expressed on cells associated with immune function (for reviews see refs 1, 2, 5), and are involved in mediating T-cell, B-cell and macrophage interactions required for the generation of immune responses(6-9). In addition, both consist of two non-covalently associated polypeptides, designated alpha and beta, with molecular weights of 34,000 and 28,000, respectively(10). The association of some DR antigens with increased susceptibility to certain diseases (for review see ref. 1) and the genetic restrictions imposed on cellular interactions by the HLA-D region(9,11) may represent the effects of structural variability among DR antigens. The aim of the studies reported here was to examine the nature and degree of structural variation among DR antigens isolated from cultured lymphoid B cells with different DR phenotypes. Such information may provide an understanding of the molecular mechanisms by which DR antigens mediate their function.

Entities:  

Year:  1979        PMID: 16068184     DOI: 10.1038/279436a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Southern blot and microfingerprinting analysis of two DR7 haplotypes.

Authors:  G Angelini; N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Both chains of HLA-DR bind to the membrane with a penultimate hydrophobic region and the heavy chain is phosphorylated at its hydrophilic carboxyl terminus.

Authors:  J F Kaufman; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits.

Authors:  V Quaranta; N Tanigaki; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system.

Authors:  M L Markert; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

5.  Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells.

Authors:  D Owerbach; A Lernmark; L Rask; P A Peterson; P Platz; A Svejgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Expression of T-lymphoblast-encoded HLA-DR antigens on human T-B lymphoblast hybrids.

Authors:  D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Isolation and identification of a cDNA clone corresponding to an HLA-DR antigen beta chain.

Authors:  K Wiman; D Larhammar; L Claesson; K Gustafsson; L Schenning; P Bill; J Böhme; M Denaro; B Dobberstein; U Hammerling; S Kvist; B Servenius; J Sundelin; P A Peterson; L Rask
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.

Authors:  D A Shackelford; D L Mann; J J van Rood; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.

Authors:  B S Nepom; G T Nepom; E Mickelson; P Antonelli; J A Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

10.  Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.

Authors:  Gunnveig Grodeland; Agnete Brunsvik Fredriksen; Geir Åge Løset; Elisabeth Vikse; Lars Fugger; Bjarne Bogen
Journal:  J Immunol       Date:  2016-09-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.